Human skin absorption and metabolism of the contact allergens, cinnamic aldehyde, and cinnamic alcohol.
trans-Cinnamaldehyde and trans-cinnamic alcohol have been commonly reported to cause allergic contact dermatitis (ACD) in humans. Cinnamaldehyde is a more potent skin sensitizer than cinnamic alcohol. It has been hypothesized that cinnamic alcohol is a "prohapten" that requires metabolic activation, presumably by oxidoreductase enzymes such as alcohol dehydrogenase (ADH) or cytochrome P450 2E1 (CYP2E1), to the protein-reactive cinnamaldehyde (a hapten). In this study, the in vitro percutaneous absorption and metabolism of cinnamaldehyde and cinnamic alcohol (78 micromol dose) has been examined using freshly excised, metabolically viable, full-thickness breast and abdomen skin from six female donors. Penetration rates and total cumulative recoveries of cinnamic compounds that were present in receptor fluid, extracted from within the skin, evaporated from the skin surface, or remained unabsorbed on the skin surface after 24 h were quantified by reversed-phase high-performance liquid chromatography. Biotransformation of cinnamaldehyde to both cinnamic alcohol and cinnamic acid was observed. Topically applied cinnamic alcohol was converted to cinnamaldehyde (found on the skin surface only) and cinnamic acid. To establish whether these biotransformations were enzymatic, experiments were performed in the absence and presence of varying concentrations (80-320 micromol) of the ADH/CYP2E1 inhibitors pyrazole or 4-methylpyrazole. The observation that pyrazole significantly reduced (p < 0.05) the total penetration of cinnamic metabolites into receptor fluid, following either cinnamaldehyde or cinnamic alcohol treatment, but did not significantly affect parent chemical penetration, suggests that we are measuring cutaneous metabolic products of ADH activity. The skin absorption and metabolism of cinnamaldehyde and cinnamic alcohol will play an important role in the manifestation of ACD following topical exposure to these compounds.
Smith
C K
CK
Section of Molecular Toxicology, Division of Biomedical Sciences, Imperial College School of Medicine, Sir Alexander Fleming Building, London, SW7 2AZ, United Kingdom.
Moore
C A
CA
Elahi
E N
EN
Smart
A T
AT
Hotchkiss
S A
SA
D000171:Acrolein / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D000328:Adult; D000485:Allergens / Q000378:metabolism*; D001711:Biotransformation; D002851:Chromatography, High Pressure Liquid; D017449:Dermatitis, Allergic Contact; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008875:Middle Aged; D020005:Propanols / Q000493:pharmacokinetics*; D011720:Pyrazoles / Q000494:pharmacology; D012869:Skin Absorption / Q000502:physiology*
D000485:Allergens; D020005:Propanols; D011720:Pyrazoles; D000171:Acrolein; C012843:cinnamaldehyde; C020722:cinnamyl alcohol